¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦37Â÷ KSTH Ãá°èÇмú´ëȸ : 2020-07-31

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦37Â÷ KSTH Ãá°èÇмú´ëȸ : 2020-07-31
±³À°ÀÏÀÚ : 2020-07-31
±³À°Àå¼Ò : ¼¼Á¾´ëÇб³ ¼¼Á¾ÄÁº¥¼ÇȦ ÁöÇÏ1Ãþ ÄÁÆÛ·±½º 2°³·ë  
±³À°ÁÖÁ¦ : Á¦37Â÷ KSTH Ãá°èÇмú´ëȸ
ÁÖÃÖ±â°ü : Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ
´ã´çÀÚ : ±èÁø¾Æ
¿¬¶ôó : 042-484-2426  
À̸ÞÀÏ : ksth@thrombo.or.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, Á¤½Å°Ç°­ÀÇÇаú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, À̺ñÀÎÈÄ°ú, ¿µ»óÀÇÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú, °áÇÙ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаúÀÇ»çÇÐ, ¿¹¹æÀÇÇÐ, »ý¸®ÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ÀÇ·á»çȸÇÐ, ÀÇ·áÀ±¸®ÇÐ, ÀÇ·á»çȸ½É¸®ÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇÇб³À°, ÀÇ·áÁ¤Ã¥, ÀÇ·á°æ¿µ, ±âŸ,      
Âü¼®¿¹»óÀοø : 120¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07-31 ÄÁÆÛ·±½ºA·ë 09:30~09:50 Current evidence-based treatment for ITP  ÃÖÀºÁö(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 07-31 ÄÁÆÛ·±½ºA·ë 09:50~10:10 New treatment approach for refractory ITP  ¹Ú¿µÈÆ(Ä«Å縯ÀÇ´ë) 
±³À°½Ã°£ 07-31 ÄÁÆÛ·±½ºA·ë 10:10~10:30 Treatment of PNH: eculizumab and thereafter  ±èÇõ(°¡ÃµÀÇ´ë) 
È޽Ġ07-31  10:30~11:00 Coffee Break  () 
±³À°½Ã°£ 07-31 ÄÁÆÛ·±½ºA·ë 11:00~11:20 Differential diagnosis of TMA  È«ÁؽÄ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 07-31 ÄÁÆÛ·±½ºA·ë 11:20~11:40 Pathogenesis and treatment of transplant-associated TMA  À¯Àº»ó(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 07-31 ÄÁÆÛ·±½ºA·ë 11:40~12:00 Long-term outcomes after treatment in TTP patients  ¹è¼ºÈ­(´ë±¸Ä«Å縯ÀÇ´ë) 
±³À°½Ã°£ 07-31 ÄÁÆÛ·±½ºA·ë 12:00~12:50 Strategies of antiplatelet therapy after PCI in AF patients  ±è¹«Çö(µ¿¾ÆÀÇ´ë) 
±³À°½Ã°£ 07-31 ÄÁÆÛ·±½ºA·ë 12:50~14:30 Lunch ¹× Oral presentation  Á¤¸íÈ£(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 07-31 ÄÁÆÛ·±½ºA·ë 14:30~14:45 Antithrombotics in Multiple Combined CV ds: ACS, Stroke, Af, and VTE  ³ª»óÈÆ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 07-31 ÄÁÆÛ·±½ºA·ë 14:45~15:00 Update of Escalation and De-escalation Strategy of DAPT after PCI  À§Áø(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 07-31 ÄÁÆÛ·±½ºA·ë 15:00~15:15 DAPT Updates: What Is Optimal Combination Strategy in Asian AMI?  ¹Ú¿ëÈÖ(°æ»óÀÇ´ë) 
Åä·Ð 07-31 ÄÁÆÛ·±½ºA·ë 15:15~15:30 Panel discussion  Çã¾Ö¿µ,ÃÖö¿õ(°­¿øÀÇ´ë,°í·ÁÀÇ´ë) 
È޽Ġ07-31  15:30~16:00 Coffee Break  () 
±³À°½Ã°£ 07-31 ÄÁÆÛ·±½ºA·ë 16:00~16:15 Risk Stratification of Stroke and Thromboembolism in AF  ±èÁ¤¹Î(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 07-31 ÄÁÆÛ·±½ºA·ë 16:15~16:30 Optimal Antithrombotics after PCI with Af –Interventionist¡¯s view  ÀÌ¿øÀç(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 07-31 ÄÁÆÛ·±½ºA·ë 16:30~16:45 Optimal Antithrombotics after PCI with Af –EP guy¡¯s view  ÀÌÁöÇö(¼­¿ïÀÇ´ë) 
Åä·Ð 07-31 ÄÁÆÛ·±½ºA·ë 16:45~17:00 Panel discussion II  ÀÌÁ¤¸í,½ÅÀº¼®(°æÈñÀÇ´ë,¿ï»êÀÇ´ë) 
±âŸ 07-31 ÄÁÆÛ·±½ºA·ë 17:00~17:30 ¿ì¼ö¿¬Á¦»ó ¹ßÇ¥ ¹× ½Ã»ó  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦37Â÷ KSTH Ãá°èÇмú´ëȸ : 2020-07-31""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑ°£¾ÏÇÐȸ Á¦14Â÷ Á¤±âÇмú´ëȸ(¿Â¶óÀÎ) : 2020-07-31
´ÙÀ½±Û 2020 ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ Á¦64Â÷ Çмú´ëȸ : 2020-07-30
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20634 ´ëÀü 2024³â ´ëÀü±¤¿ª½ÃÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-05-18 0 12 2024-05-10
20633 ¼­¿ï ´ëÇѾȽŰæÀÇÇÐȸ Neurology of eye movements : 2024-05-18 0 20 2024-05-10
20632 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ KSMO Á¦ 22Â÷ Ãá°èÁ¤±â½ÉÆ÷Áö¾ö ¹× ÃÑȸ : 2024-05-17 0 7 2024-05-10
20631 ÀÎõ 2024³âµµ Á¦47Â÷ ´ëÇѺ¹ºÎ¿µ»óÀÇÇÐȸ Çмú´ëȸ(1ÀÏÂ÷) : 2024-05-17 0 4 2024-05-10
20630 ºÎ»ê Á¦28Â÷ ¾Æ½Ã¾Æ-¿À¼¼¾Æ´Ï¾Æ »êºÎÀΰú¿¬¸Í Çмú´ëȸ (AOFOG 2024) (1ÀÏÂ÷) : 2024-05-17 0 7 2024-05-10
20629 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ¿Â¶óÀÎ_¼­¿ï°æÀÎÁöȸ 276Â÷ ¿ù·ÊÁý´ãȸ : 2024-05-17 0 2 2024-05-10
20628 ¼­¿ï 2024³â ´ëÇѹ财Àå¾Ö¿ä½Ç±ÝÇÐȸ Ãá°è ½ÉÆ÷Áö¾ö : 2024-05-17 0 8 2024-05-10
20627 ´ëÀü ´ëÇÑ»êºÎÀΰúÀÇ»çȸ ´ëÀüÁöȸ ¿¬¼ö±³À° : 2024-05-17 0 15 2024-05-10
20626 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-05-13 0 15 2024-05-10
20625 ´ëÀü Çѱ¹¿©ÀÚÀÇ»çȸ ´ëÀüÁöȸ 5¿ù Çмú½ÉÆ÷Áö¾ö(¾î±ú ÅëÁõ) : 2024-05-13 0 8 2024-05-10
20624 ¼­¿ï ´ëÇÑ·¹ÀÌÀúÇǺθð¹ßÇÐȸ Á¦46Â÷ Ãá°è Çмú´ëȸ : 2024-05-12 0 8 2024-05-10
20623 ¼­¿ï Á¦2ȸ ´ëÇѽŰæ°úÀÇ»çȸ Ãá°è ÀçÅÃÀÇ·á ½ÉÆ÷Áö¾ö : 2024-05-12 0 21 2024-05-10
20622 ´ë±¸ Á¦54ȸ ´ëÇѵΰæºÎ¿Ü°úÇÐȸ Áõ·ÊÇмú´ëȸ : 2024-05-11 0 11 2024-05-10
20621 °æºÏ 2024³â Á¦28ȸ ´ëÇÑÀü¸³¼±·¹ÀÌÀú¿¬±¸ÇÐȸ ÁýÁß½ÉÆ÷Áö¾ö : 2024-05-10 0 7 2024-05-10
20620 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼­¿ï¾Æ»êº´¿ø ´ç´¢º´ °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-30 0 168 2024-04-30
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷